1. Home
  2. RNW vs GLPG Comparison

RNW vs GLPG Comparison

Compare RNW & GLPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ReNew Energy Global plc

RNW

ReNew Energy Global plc

HOLD

Current Price

$5.32

Market Cap

1.9B

Sector

Utilities

ML Signal

HOLD

Logo Galapagos NV

GLPG

Galapagos NV

HOLD

Current Price

$32.79

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RNW
GLPG
Founded
2011
1999
Country
United Kingdom
Belgium
Employees
4336
704
Industry
Electric Utilities: Central
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RNW
GLPG
Price
$5.32
$32.79
Analyst Decision
Hold
Buy
Analyst Count
1
2
Target Price
$7.00
$36.50
AVG Volume (30 Days)
640.2K
109.2K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$9.97
N/A
P/E Ratio
$14.63
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.05
$22.59
52 Week High
$8.24
$37.78

Technical Indicators

Market Signals
Indicator
RNW
GLPG
Relative Strength Index (RSI) 44.40 44.96
Support Level $5.27 $31.88
Resistance Level $5.63 $33.67
Average True Range (ATR) 0.13 0.71
MACD -0.01 -0.17
Stochastic Oscillator 39.11 34.20

Price Performance

Historical Comparison
RNW
GLPG

About RNW ReNew Energy Global plc

ReNew Energy Global PLC is a developer and operator of clean energy projects intended to meet India's growing energy needs in an efficient, sustainable and socially responsible manner. The company provides end-to-end solutions in a just and inclusive manner in the areas of clean energy, value-added energy offerings through digitalization, storage, and carbon markets that increasingly are integral to addressing climate change. The company has four reportable segments: wind power and solar power, hydro power and transmission line. It derives maximum revenue from Wind Power segment.

About GLPG Galapagos NV

Galapagos NV is a fully integrated biotechnology company with operations in Europe and the United States, dedicated to developing medicines focusing on oncology and immunology. The group focuses on unmet medical needs, it synergizes compelling science, technology, and collaborative approaches to create a deep pipeline of medicines. Its clinical pipeline includes: GLPG5101, a CD19 CAR-T product candidate decentralized manufactured, currently in Phase 1/2 in rrNHL; GLPG5301, a BCMA CAR-T product candidate decentralized manufactured, currently in Phase 1 in rrMM; and GLPG3667, a TYK2 inhibitor currently in Phase 2 clinical trial in DM and SLE. It derives maximum revenue from the United States of America.

Share on Social Networks: